nepafenac has been researched along with Pain, Postoperative in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chronopoulou, KG; Kontadakis, GA; Kymionis, GD; Tabibian, D; Tsopouridou, R | 1 |
| Oğurel, R; Oğurel, T; Onaran, Z; Örnek, K | 1 |
| Jones, BM; Neville, MW | 1 |
| Bukus, A; Demir, LS; Goktas, S; Ozcimen, M; Sakarya, R; Sakarya, Y; Yener, HI | 1 |
| Achiron, A; Burgansky, Z; Dzhanov, Y; Gershoni, A; Gur, Z; Karmona, L; Mimouni, M | 1 |
| Cavanagh, HD; Maxwell, WA; Meuse, PA; Reiser, HJ; Sager, DP; Stewart, RH; Walters, TR | 1 |
| Gow, JA; McNamara, TR; Song, CK | 1 |
| Garg, S; Khanduja, S; Kumar, S; Naithani, P; Puranik, S; Vashisht, N | 1 |
| Hanemoto, T; Hayashi, K; Miyake, S; Miyata, K; Noge, S; Numaga, J; Saito, I; Yabe, N; Yata, K | 1 |
| Colin, J; Paquette, B | 1 |
| Holland, EJ; Lane, SS; Lehmann, RP; Modi, SS | 1 |
| McDonald, M; Trattler, W | 1 |
| Chalkley, TH; Duong, HV; Westfield, KC | 1 |
| McCulley, JP | 1 |
| Toyos, R | 1 |
| Holland, E; Lane, S; Lindstrom, R; Raizman, M; Reilly, C | 1 |
| Caldwell, M; Reilly, C | 1 |
1 review(s) available for nepafenac and Pain, Postoperative
| Article | Year |
|---|---|
Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Clinical Trials as Topic; Humans; Pain, Postoperative; Phenylacetates | 2013 |
10 trial(s) available for nepafenac and Pain, Postoperative
| Article | Year |
|---|---|
Nepafenac Ophthalmic Suspension 0.3% for the Management of Ocular Pain After Photorefractive Keratectomy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Astigmatism; Benzeneacetamides; Eye Pain; Female; Humans; Lasers, Excimer; Male; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Photorefractive Keratectomy; Prospective Studies; Suspensions; Visual Acuity; Wound Healing; Young Adult | 2018 |
Effect of nepafenac eye drops on pain associated with pterygium surgery.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative; Phenylacetates; Pterygium | 2015 |
Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Double-Blind Method; Drug Administration Schedule; Eye Diseases; Female; Humans; Inflammation; Male; Middle Aged; Pain, Postoperative; Phenylacetates; Prospective Studies; Treatment Failure | 2008 |
Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Eye Pain; Female; Humans; Macular Edema; Male; Pain, Postoperative; Phenylacetates; Visual Acuity; Vitreoretinal Surgery | 2012 |
[Phase III open-label study of nepafenac ophthalmic suspension 0.1% for inflammation and ocular pain following ophthalmic surgery].
Topics: Adult; Aged; Benzeneacetamides; Eye Diseases; Eye Pain; Female; Humans; Inflammation; Male; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pain, Postoperative; Phenylacetates; Treatment Outcome | 2012 |
Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Diclofenac; Double-Blind Method; Female; Humans; Keratotomy, Radial; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative; Phenylacetates; Photophobia; Postoperative Complications; Suspensions | 2006 |
Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phacoemulsification; Phenylacetates; Uveitis, Anterior; Visual Acuity | 2007 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Female; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Male; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Prospective Studies; Visual Acuity; Wound Healing | 2007 |
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative; Patient Compliance; Patient Satisfaction; Phacoemulsification; Phenylacetates; Prospective Studies; Uveitis, Anterior; Visual Acuity | 2007 |
Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: a bilateral, prospective, randomized, masked trial.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Epithelium, Corneal; Female; Humans; Lasers, Excimer; Male; Middle Aged; Pain, Postoperative; Phenylacetates; Photorefractive Keratectomy; Prospective Studies; Time Factors; Wound Healing | 2008 |
7 other study(ies) available for nepafenac and Pain, Postoperative
| Article | Year |
|---|---|
0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery.
Topics: Administration, Topical; Aged; Anesthesia, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Intraoperative Period; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Phenylacetates; Prospective Studies; Treatment Outcome | 2018 |
Comparison of the Tolerability of Diclofenac and Nepafenac.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Diclofenac; Double-Blind Method; Female; Humans; Inflammation; Male; Molecular Structure; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Prospective Studies; Visual Analog Scale | 2016 |
Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Clinical Trials as Topic; Drug Administration Schedule; Drug Approval; Humans; Inflammation; Pain, Postoperative; Phenylacetates; United States; United States Food and Drug Administration | 2009 |
Nepafenac: new drug. After cataract surgery: just another NSAID eye drop. No better than other NSAID eye drops, and less convenient to use.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Double-Blind Method; Drug Approval; Europe; Humans; Inflammation; Ophthalmic Solutions; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic | 2009 |
Ketorolac versus nepafenac in cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Humans; Ketorolac Tromethamine; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Ophthalmic Solutions; Pain, Postoperative; Patient Compliance; Patient Satisfaction; Phacoemulsification; Phenylacetates; Uveitis, Anterior; Visual Acuity | 2008 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Multicenter Studies as Topic; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic; Visual Acuity; Wound Healing | 2008 |
Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cornea; Corneal Opacity; Double-Blind Method; Humans; Hyperopia; Keratomileusis, Laser In Situ; Ketorolac Tromethamine; Myopia; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic; Visual Acuity; Wound Healing | 2008 |